

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.73142120 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.94142400 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.20756706 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.20756706 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.20756706 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.20756706 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.20756706 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.20756706 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.34986647 |
| 10 | respiratory burst (GO:0045730) | 5.23408178 |
| 11 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.98808863 |
| 12 | oligosaccharide catabolic process (GO:0009313) | 4.93322847 |
| 13 | granulocyte activation (GO:0036230) | 4.78610573 |
| 14 | superoxide anion generation (GO:0042554) | 4.61814086 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.60130599 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.55305912 |
| 17 | amino sugar catabolic process (GO:0046348) | 4.53539833 |
| 18 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.47799459 |
| 19 | glycosphingolipid catabolic process (GO:0046479) | 4.47775050 |
| 20 | neutrophil activation (GO:0042119) | 4.44240581 |
| 21 | reactive oxygen species biosynthetic process (GO:1903409) | 4.38688617 |
| 22 | response to peptidoglycan (GO:0032494) | 4.33151666 |
| 23 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.25695292 |
| 24 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 4.20178191 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.18476964 |
| 26 | phagocytosis, recognition (GO:0006910) | 4.17474675 |
| 27 | myeloid cell activation involved in immune response (GO:0002275) | 4.15355525 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 4.11932787 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 4.09194263 |
| 30 | ceramide catabolic process (GO:0046514) | 4.03818067 |
| 31 | regulation of mononuclear cell migration (GO:0071675) | 4.02360355 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.02059332 |
| 33 | glycolipid catabolic process (GO:0019377) | 4.01347733 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.00903811 |
| 35 | response to host immune response (GO:0052572) | 4.00903811 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 3.93535365 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.90204493 |
| 38 | tryptophan catabolic process (GO:0006569) | 3.85090006 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.85090006 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.85090006 |
| 41 | wound healing, spreading of epidermal cells (GO:0035313) | 3.84120588 |
| 42 | cellular response to zinc ion (GO:0071294) | 3.82502738 |
| 43 | positive regulation of heat generation (GO:0031652) | 3.81269325 |
| 44 | positive regulation of mast cell degranulation (GO:0043306) | 3.81218968 |
| 45 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.81218968 |
| 46 | eosinophil chemotaxis (GO:0048245) | 3.80499120 |
| 47 | regulation of cholesterol storage (GO:0010885) | 3.79952677 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 3.75466032 |
| 49 | positive regulation of macrophage cytokine production (GO:0060907) | 3.74836151 |
| 50 | macrophage activation (GO:0042116) | 3.71743678 |
| 51 | * phagosome maturation (GO:0090382) | 3.67070887 |
| 52 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.66212321 |
| 53 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.66050676 |
| 54 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.60816774 |
| 55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.59859297 |
| 56 | negative regulation of interleukin-17 production (GO:0032700) | 3.56415669 |
| 57 | natural killer cell mediated immunity (GO:0002228) | 3.54432099 |
| 58 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.54432099 |
| 59 | kynurenine metabolic process (GO:0070189) | 3.52063124 |
| 60 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.50716872 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 3.50085356 |
| 62 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.47973101 |
| 63 | response to host (GO:0075136) | 3.47973101 |
| 64 | response to host defenses (GO:0052200) | 3.47973101 |
| 65 | microglial cell activation (GO:0001774) | 3.47967950 |
| 66 | regulation of mast cell activation (GO:0033003) | 3.46066801 |
| 67 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.45848415 |
| 68 | regulation of chronic inflammatory response (GO:0002676) | 3.39229765 |
| 69 | glucosamine-containing compound catabolic process (GO:1901072) | 3.37526475 |
| 70 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.37018019 |
| 71 | regulation of heat generation (GO:0031650) | 3.34348992 |
| 72 | eosinophil migration (GO:0072677) | 3.33949976 |
| 73 | platelet dense granule organization (GO:0060155) | 3.32348080 |
| 74 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.32148711 |
| 75 | negative regulation of mast cell activation (GO:0033004) | 3.32120650 |
| 76 | positive regulation of leukocyte degranulation (GO:0043302) | 3.28172059 |
| 77 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.27519472 |
| 78 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.27519407 |
| 79 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25960220 |
| 80 | aldehyde catabolic process (GO:0046185) | 3.25506133 |
| 81 | regulation of fever generation (GO:0031620) | 3.25400719 |
| 82 | protein K11-linked deubiquitination (GO:0035871) | 3.25306711 |
| 83 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.24311937 |
| 84 | membrane lipid catabolic process (GO:0046466) | 3.23161997 |
| 85 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.22502032 |
| 86 | cellular response to ATP (GO:0071318) | 3.21367617 |
| 87 | sphingolipid catabolic process (GO:0030149) | 3.20332522 |
| 88 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.19703884 |
| 89 | low-density lipoprotein particle clearance (GO:0034383) | 3.19590720 |
| 90 | monocyte chemotaxis (GO:0002548) | 3.19071861 |
| 91 | keratan sulfate catabolic process (GO:0042340) | 3.18611689 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18514067 |
| 93 | positive regulation of interferon-beta production (GO:0032728) | 3.15485569 |
| 94 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14278332 |
| 95 | positive regulation of prostaglandin secretion (GO:0032308) | 3.12632327 |
| 96 | tryptophan metabolic process (GO:0006568) | 3.12588724 |
| 97 | N-acetylneuraminate metabolic process (GO:0006054) | 3.11593693 |
| 98 | vitamin D metabolic process (GO:0042359) | 3.09482909 |
| 99 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07716594 |
| 100 | tooth mineralization (GO:0034505) | 3.06847978 |
| 101 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.06388724 |
| 102 | * ATP hydrolysis coupled proton transport (GO:0015991) | 3.06388724 |
| 103 | defense response to protozoan (GO:0042832) | 3.06166205 |
| 104 | intracellular pH reduction (GO:0051452) | 3.06122349 |
| 105 | myeloid leukocyte activation (GO:0002274) | 3.04868127 |
| 106 | positive regulation of osteoclast differentiation (GO:0045672) | 3.02337618 |
| 107 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.01846854 |
| 108 | detection of external biotic stimulus (GO:0098581) | 3.01195301 |
| 109 | myeloid dendritic cell differentiation (GO:0043011) | 3.00935828 |
| 110 | cellular biogenic amine catabolic process (GO:0042402) | 2.98468164 |
| 111 | amine catabolic process (GO:0009310) | 2.98468164 |
| 112 | leukocyte mediated cytotoxicity (GO:0001909) | 2.96824672 |
| 113 | indolalkylamine metabolic process (GO:0006586) | 2.95699087 |
| 114 | B cell mediated immunity (GO:0019724) | 2.95364376 |
| 115 | negative regulation of lipid storage (GO:0010888) | 2.94557687 |
| 116 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.94331703 |
| 117 | negative regulation of interleukin-1 production (GO:0032692) | 2.92653638 |
| 118 | regulation of chemokine biosynthetic process (GO:0045073) | 2.90923862 |
| 119 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.90804814 |
| 120 | regulation of macrophage cytokine production (GO:0010935) | 2.90270099 |
| 121 | neutrophil chemotaxis (GO:0030593) | 2.87421193 |
| 122 | positive regulation of interleukin-6 production (GO:0032755) | 2.87027219 |
| 123 | ganglioside metabolic process (GO:0001573) | 2.86521538 |
| 124 | myeloid dendritic cell activation (GO:0001773) | 2.85911707 |
| 125 | regulation of leukocyte degranulation (GO:0043300) | 2.85775500 |
| 126 | regulation of T-helper 1 type immune response (GO:0002825) | 2.81430867 |
| 127 | response to muramyl dipeptide (GO:0032495) | 2.80812824 |
| 128 | neutrophil migration (GO:1990266) | 2.80710103 |
| 129 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.80490582 |
| 130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.80127730 |
| 131 | leukocyte aggregation (GO:0070486) | 2.79384416 |
| 132 | T-helper 1 type immune response (GO:0042088) | 2.79072208 |
| 133 | pH reduction (GO:0045851) | 2.79001937 |
| 134 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.78200893 |
| 135 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.76332057 |
| 136 | regulation of prostaglandin secretion (GO:0032306) | 2.75312155 |
| 137 | response to thyroid hormone (GO:0097066) | 2.74918883 |
| 138 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.74657291 |
| 139 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.74231713 |
| 140 | positive regulation of lipid storage (GO:0010884) | 2.71969790 |
| 141 | regulation of monocyte chemotaxis (GO:0090025) | 2.71541379 |
| 142 | superoxide metabolic process (GO:0006801) | 2.71240932 |
| 143 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.71013162 |
| 144 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70442060 |
| 145 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.69934278 |
| 146 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.69356513 |
| 147 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69356513 |
| 148 | lytic vacuole organization (GO:0080171) | 2.66683205 |
| 149 | lysosome organization (GO:0007040) | 2.66683205 |
| 150 | macrophage chemotaxis (GO:0048246) | 2.66290282 |
| 151 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.65493495 |
| 152 | positive regulation of chemokine production (GO:0032722) | 2.64860321 |
| 153 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.63889021 |
| 154 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.61311847 |
| 155 | positive regulation of calcium ion import (GO:0090280) | 2.56529609 |
| 156 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.55317165 |
| 157 | response to lipoprotein particle (GO:0055094) | 2.51552838 |
| 158 | neuromuscular process controlling posture (GO:0050884) | 2.49473446 |
| 159 | DNA deamination (GO:0045006) | 2.49111982 |
| 160 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.48577224 |
| 161 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.48466281 |
| 162 | sphingosine metabolic process (GO:0006670) | 2.48264940 |
| 163 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.48094710 |
| 164 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.47159248 |
| 165 | positive regulation of defense response to virus by host (GO:0002230) | 2.46570160 |
| 166 | vitamin biosynthetic process (GO:0009110) | 2.46041687 |
| 167 | regulation of T-helper cell differentiation (GO:0045622) | 2.45810841 |
| 168 | behavioral response to nicotine (GO:0035095) | 2.43554715 |
| 169 | response to xenobiotic stimulus (GO:0009410) | 2.42948786 |
| 170 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.41099703 |
| 171 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.40721715 |
| 172 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.40607756 |
| 173 | regulation of vitamin metabolic process (GO:0030656) | 2.39019126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.01845535 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.98779180 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.34328350 |
| 4 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.83098424 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.41799452 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.21022377 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.82679587 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.27738499 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.13087624 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.10815445 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07276299 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.97454272 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.85002544 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.83012767 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.73447349 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.66872135 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30819319 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.27106178 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26305993 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20365946 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12941941 |
| 22 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.11533696 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02153783 |
| 24 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98869953 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91908922 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.89967864 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.87865898 |
| 28 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.83773233 |
| 29 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81357954 |
| 30 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.79679652 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.79447122 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78182155 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.76971287 |
| 34 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.71914051 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.71741310 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.70893988 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59730673 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51345165 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.50676201 |
| 40 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.50676201 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50273511 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48682138 |
| 43 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46114263 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45687415 |
| 45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.45140393 |
| 46 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45086171 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44764500 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44221574 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43850445 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43107643 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42856435 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42682164 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40552750 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39986696 |
| 55 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.38998271 |
| 56 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38998271 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.38845007 |
| 58 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38546677 |
| 59 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37289567 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36668732 |
| 61 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.34905268 |
| 62 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.34905268 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34275011 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33543379 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33325060 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32739123 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31430633 |
| 68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30873146 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30561971 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30518389 |
| 71 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.30412609 |
| 72 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30202903 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29745563 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.29173385 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28783251 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26508766 |
| 77 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.22115420 |
| 78 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22115420 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21548868 |
| 80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20931482 |
| 81 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20622618 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20407301 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20384329 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20151732 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19274857 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18337105 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18255799 |
| 88 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.18122402 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17557026 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17272727 |
| 91 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17040050 |
| 92 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16024322 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15662130 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.15061458 |
| 95 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14259103 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14036350 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12706996 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12222181 |
| 99 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11820862 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11498456 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11187863 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10986255 |
| 103 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10710016 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10315650 |
| 105 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10014175 |
| 106 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09899293 |
| 107 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09561118 |
| 108 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09561118 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09488850 |
| 110 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09392904 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09225329 |
| 112 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08481171 |
| 113 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08358580 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07480911 |
| 115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04485287 |
| 116 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03697143 |
| 117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03496880 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03048001 |
| 119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02285561 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01755151 |
| 121 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01633214 |
| 122 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00807926 |
| 123 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00309017 |
| 124 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00240963 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00080054 |
| 126 | MAF_26560356_Chip-Seq_TH1_Human | 0.98689484 |
| 127 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97981149 |
| 128 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97787789 |
| 129 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97772198 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97737475 |
| 131 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97690271 |
| 132 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97062299 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96485631 |
| 134 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96465454 |
| 135 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95385709 |
| 136 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94965215 |
| 137 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94789475 |
| 138 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94417078 |
| 139 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.94397770 |
| 140 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.93865176 |
| 141 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93842707 |
| 142 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93609092 |
| 143 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93592610 |
| 144 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93446722 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93226253 |
| 146 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92850484 |
| 147 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92268620 |
| 148 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91358830 |
| 149 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.90734639 |
| 150 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90576511 |
| 151 | MYB_26560356_Chip-Seq_TH1_Human | 0.89494000 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89379031 |
| 153 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88566100 |
| 154 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87089294 |
| 155 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86668254 |
| 156 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86248750 |
| 157 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85248391 |
| 158 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84602599 |
| 159 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84128777 |
| 160 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81013928 |
| 161 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78333046 |
| 162 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77102870 |
| 163 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77043601 |
| 164 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76474724 |
| 165 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76075703 |
| 166 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.75810516 |
| 167 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73906592 |
| 168 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73906592 |
| 169 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72156359 |
| 170 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72050971 |
| 171 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.71219082 |
| 172 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70522256 |
| 173 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.70037703 |
| 174 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.69455552 |
| 175 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.68636685 |
| 176 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67443728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.38017547 |
| 2 | MP0003436_decreased_susceptibility_to | 4.04766104 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.84069083 |
| 4 | MP0006082_CNS_inflammation | 3.73240353 |
| 5 | MP0003303_peritoneal_inflammation | 3.49120431 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.46111942 |
| 7 | MP0002419_abnormal_innate_immunity | 3.39990559 |
| 8 | MP0009785_altered_susceptibility_to | 3.19064932 |
| 9 | MP0003724_increased_susceptibility_to | 3.11303276 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 3.07283166 |
| 11 | MP0005000_abnormal_immune_tolerance | 3.00469000 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.90716873 |
| 13 | MP0005025_abnormal_response_to | 2.77865858 |
| 14 | MP0004510_myositis | 2.68073434 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.66756875 |
| 16 | MP0005084_abnormal_gallbladder_morpholo | 2.57499903 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.46775808 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.42725402 |
| 19 | MP0005387_immune_system_phenotype | 2.30705297 |
| 20 | MP0001790_abnormal_immune_system | 2.30705297 |
| 21 | MP0002723_abnormal_immune_serum | 2.18766345 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.06755992 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.02363988 |
| 24 | MP0001819_abnormal_immune_cell | 1.99784956 |
| 25 | MP0005671_abnormal_response_to | 1.96878739 |
| 26 | MP0009764_decreased_sensitivity_to | 1.96618779 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.96445031 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.96256705 |
| 29 | MP0003075_altered_response_to | 1.88555663 |
| 30 | MP0002405_respiratory_system_inflammati | 1.88372082 |
| 31 | MP0000343_altered_response_to | 1.88329671 |
| 32 | MP0001800_abnormal_humoral_immune | 1.87766024 |
| 33 | MP0001853_heart_inflammation | 1.87334459 |
| 34 | MP0003690_abnormal_glial_cell | 1.85249061 |
| 35 | MP0009840_abnormal_foam_cell | 1.85212666 |
| 36 | MP0003646_muscle_fatigue | 1.84959950 |
| 37 | MP0005166_decreased_susceptibility_to | 1.82821352 |
| 38 | MP0000685_abnormal_immune_system | 1.82266281 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.78508422 |
| 40 | MP0003448_altered_tumor_morphology | 1.76936810 |
| 41 | * MP0002998_abnormal_bone_remodeling | 1.73384585 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.73148656 |
| 43 | MP0005365_abnormal_bile_salt | 1.68928608 |
| 44 | MP0004782_abnormal_surfactant_physiolog | 1.66676736 |
| 45 | MP0008469_abnormal_protein_level | 1.60531453 |
| 46 | MP0005310_abnormal_salivary_gland | 1.60245539 |
| 47 | MP0004947_skin_inflammation | 1.55544579 |
| 48 | MP0000604_amyloidosis | 1.55231908 |
| 49 | MP0003186_abnormal_redox_activity | 1.53194271 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.50805427 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.40074832 |
| 52 | MP0005379_endocrine/exocrine_gland_phen | 1.38313852 |
| 53 | MP0004043_abnormal_pH_regulation | 1.37164097 |
| 54 | MP0002254_reproductive_system_inflammat | 1.35502432 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.32908443 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.31369951 |
| 57 | MP0000858_altered_metastatic_potential | 1.30960434 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.30367316 |
| 59 | MP0006054_spinal_hemorrhage | 1.27763007 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25922632 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.25234788 |
| 62 | * MP0000716_abnormal_immune_system | 1.24707698 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.24394678 |
| 64 | MP0001851_eye_inflammation | 1.22000163 |
| 65 | MP0003329_amyloid_beta_deposits | 1.18936278 |
| 66 | MP0002653_abnormal_ependyma_morphology | 1.18509984 |
| 67 | MP0003136_yellow_coat_color | 1.18067653 |
| 68 | MP0005164_abnormal_response_to | 1.17961054 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.17868456 |
| 70 | MP0002090_abnormal_vision | 1.16205948 |
| 71 | MP0005646_abnormal_pituitary_gland | 1.14890371 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.14450511 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 1.14267390 |
| 74 | MP0003828_pulmonary_edema | 1.11608470 |
| 75 | MP0005647_abnormal_sex_gland | 1.10072724 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.08729828 |
| 77 | MP0009046_muscle_twitch | 1.06822130 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 1.06609853 |
| 79 | MP0005253_abnormal_eye_physiology | 1.05560734 |
| 80 | MP0002006_tumorigenesis | 1.04204435 |
| 81 | MP0005377_hearing/vestibular/ear_phenot | 1.03541311 |
| 82 | MP0003878_abnormal_ear_physiology | 1.03541311 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.01133666 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 1.00653421 |
| 85 | MP0005390_skeleton_phenotype | 1.00300585 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.98294457 |
| 87 | MP0002398_abnormal_bone_marrow | 0.98002845 |
| 88 | MP0001958_emphysema | 0.97962653 |
| 89 | MP0005410_abnormal_fertilization | 0.97625233 |
| 90 | MP0000920_abnormal_myelination | 0.97076014 |
| 91 | MP0004130_abnormal_muscle_cell | 0.96464572 |
| 92 | MP0004742_abnormal_vestibular_system | 0.96429491 |
| 93 | * MP0002429_abnormal_blood_cell | 0.96195714 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.94496507 |
| 95 | MP0002933_joint_inflammation | 0.94441180 |
| 96 | MP0003195_calcinosis | 0.93267697 |
| 97 | MP0002229_neurodegeneration | 0.92484492 |
| 98 | MP0000689_abnormal_spleen_morphology | 0.91810597 |
| 99 | MP0008260_abnormal_autophagy | 0.90588336 |
| 100 | MP0002102_abnormal_ear_morphology | 0.89106866 |
| 101 | MP0004883_abnormal_blood_vessel | 0.88689321 |
| 102 | MP0009763_increased_sensitivity_to | 0.88656121 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.87506399 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.86866927 |
| 105 | MP0003633_abnormal_nervous_system | 0.86158913 |
| 106 | MP0001764_abnormal_homeostasis | 0.84632466 |
| 107 | MP0000371_diluted_coat_color | 0.83084620 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.82990913 |
| 109 | MP0002722_abnormal_immune_system | 0.82258215 |
| 110 | MP0005448_abnormal_energy_balance | 0.82215938 |
| 111 | MP0005451_abnormal_body_composition | 0.81015140 |
| 112 | MP0000372_irregular_coat_pigmentation | 0.80764115 |
| 113 | MP0003279_aneurysm | 0.79773042 |
| 114 | MP0009278_abnormal_bone_marrow | 0.79251653 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.78812610 |
| 116 | MP0000383_abnormal_hair_follicle | 0.78419236 |
| 117 | MP0000249_abnormal_blood_vessel | 0.78074430 |
| 118 | * MP0003795_abnormal_bone_structure | 0.78016332 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.77944253 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.75671781 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.75406347 |
| 122 | MP0001545_abnormal_hematopoietic_system | 0.73341111 |
| 123 | MP0005397_hematopoietic_system_phenotyp | 0.73341111 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.69048889 |
| 125 | MP0001324_abnormal_eye_pigmentation | 0.68384865 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.67996955 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.67994234 |
| 128 | MP0001663_abnormal_digestive_system | 0.67751495 |
| 129 | MP0001485_abnormal_pinna_reflex | 0.66938936 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.66339213 |
| 131 | MP0001986_abnormal_taste_sensitivity | 0.65860761 |
| 132 | MP0002064_seizures | 0.65070753 |
| 133 | MP0002295_abnormal_pulmonary_circulatio | 0.64029929 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.61773494 |
| 135 | MP0005076_abnormal_cell_differentiation | 0.60843483 |
| 136 | MP0010307_abnormal_tumor_latency | 0.60758434 |
| 137 | MP0001542_abnormal_bone_strength | 0.60602300 |
| 138 | MP0000609_abnormal_liver_physiology | 0.58468339 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.58008834 |
| 140 | MP0003011_delayed_dark_adaptation | 0.54910119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.93992606 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.79257470 |
| 3 | Recurrent abscess formation (HP:0002722) | 7.66792117 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.84293263 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 6.12338267 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.95571512 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.71551620 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.29870935 |
| 9 | Axonal loss (HP:0003447) | 4.84497820 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.59815136 |
| 11 | Gingivitis (HP:0000230) | 4.56797569 |
| 12 | Recurrent skin infections (HP:0001581) | 4.32744721 |
| 13 | Obstructive lung disease (HP:0006536) | 4.18162825 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 4.18162825 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.11565284 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.11565284 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 4.11565284 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 4.03540687 |
| 19 | Disinhibition (HP:0000734) | 3.95178950 |
| 20 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.90710423 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.76538672 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.74850346 |
| 23 | Mutism (HP:0002300) | 3.69935674 |
| 24 | Stomatitis (HP:0010280) | 3.54086774 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.39309426 |
| 26 | Orchitis (HP:0100796) | 3.27301178 |
| 27 | Polyuria (HP:0000103) | 3.25910762 |
| 28 | Myositis (HP:0100614) | 3.25052573 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.24665709 |
| 30 | Mucopolysacchariduria (HP:0008155) | 3.22501970 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.22501970 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.16311423 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.06876174 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.06876174 |
| 35 | Myocardial infarction (HP:0001658) | 3.05966690 |
| 36 | Agnosia (HP:0010524) | 3.03230733 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01627595 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01627595 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01627595 |
| 40 | Cellulitis (HP:0100658) | 2.96171461 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.96103112 |
| 42 | Optic neuritis (HP:0100653) | 2.96103112 |
| 43 | Loss of speech (HP:0002371) | 2.95412226 |
| 44 | Abnormal drinking behavior (HP:0030082) | 2.94092381 |
| 45 | Polydipsia (HP:0001959) | 2.94092381 |
| 46 | Basal ganglia calcification (HP:0002135) | 2.92071461 |
| 47 | Urticaria (HP:0001025) | 2.91765749 |
| 48 | Joint hemorrhage (HP:0005261) | 2.88787858 |
| 49 | Metaphyseal irregularity (HP:0003025) | 2.79954079 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.79793444 |
| 51 | Periodontitis (HP:0000704) | 2.69857629 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.68973782 |
| 53 | Abnormal urine output (HP:0012590) | 2.67771818 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.67034496 |
| 55 | Upper motor neuron abnormality (HP:0002127) | 2.66525877 |
| 56 | Osteomyelitis (HP:0002754) | 2.66378728 |
| 57 | Abnormality of midbrain morphology (HP:0002418) | 2.64507735 |
| 58 | Molar tooth sign on MRI (HP:0002419) | 2.64507735 |
| 59 | Nausea (HP:0002018) | 2.64056450 |
| 60 | Abolished electroretinogram (ERG) (HP:0000550) | 2.56596294 |
| 61 | Recurrent pneumonia (HP:0006532) | 2.55737286 |
| 62 | Prostate neoplasm (HP:0100787) | 2.53262788 |
| 63 | Vasculitis (HP:0002633) | 2.51233905 |
| 64 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.49858520 |
| 65 | Hyperventilation (HP:0002883) | 2.49166645 |
| 66 | Bone pain (HP:0002653) | 2.36972161 |
| 67 | Conjunctival telangiectasia (HP:0000524) | 2.36594450 |
| 68 | Purpura (HP:0000979) | 2.35789576 |
| 69 | Peripheral demyelination (HP:0011096) | 2.33315518 |
| 70 | Congenital stationary night blindness (HP:0007642) | 2.32482351 |
| 71 | Pancreatic cysts (HP:0001737) | 2.30500488 |
| 72 | Abnormality of renal excretion (HP:0011036) | 2.30285458 |
| 73 | Abnormality of the vertebral endplates (HP:0005106) | 2.26076992 |
| 74 | Pustule (HP:0200039) | 2.25480157 |
| 75 | Recurrent viral infections (HP:0004429) | 2.23903977 |
| 76 | Amelogenesis imperfecta (HP:0000705) | 2.23786556 |
| 77 | Tubulointerstitial fibrosis (HP:0005576) | 2.22885702 |
| 78 | Hemoptysis (HP:0002105) | 2.20774005 |
| 79 | Meningitis (HP:0001287) | 2.19991738 |
| 80 | Cheilitis (HP:0100825) | 2.17642745 |
| 81 | Bone cyst (HP:0012062) | 2.16144554 |
| 82 | Pathologic fracture (HP:0002756) | 2.15162636 |
| 83 | Abnormality of dental color (HP:0011073) | 2.13317033 |
| 84 | Petechiae (HP:0000967) | 2.10960474 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.10553787 |
| 86 | True hermaphroditism (HP:0010459) | 2.10306896 |
| 87 | Thick nail (HP:0001805) | 2.07116562 |
| 88 | Nephronophthisis (HP:0000090) | 2.06306504 |
| 89 | Spontaneous hematomas (HP:0007420) | 2.05777734 |
| 90 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05563618 |
| 91 | Osteolytic defects of the hand bones (HP:0009699) | 2.04081717 |
| 92 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04081717 |
| 93 | Irregular vertebral endplates (HP:0003301) | 2.03089330 |
| 94 | Gingival bleeding (HP:0000225) | 2.03059170 |
| 95 | Pancreatic fibrosis (HP:0100732) | 2.02794342 |
| 96 | Tetraparesis (HP:0002273) | 2.01187093 |
| 97 | Neurofibrillary tangles (HP:0002185) | 1.98633003 |
| 98 | Glomerulonephritis (HP:0000099) | 1.97008290 |
| 99 | Mesangial abnormality (HP:0001966) | 1.96918262 |
| 100 | Retinal atrophy (HP:0001105) | 1.96243953 |
| 101 | Poor head control (HP:0002421) | 1.95788431 |
| 102 | Inappropriate behavior (HP:0000719) | 1.95601861 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94154293 |
| 104 | Mucosal telangiectasiae (HP:0100579) | 1.93434689 |
| 105 | Agitation (HP:0000713) | 1.93277509 |
| 106 | Hypomagnesemia (HP:0002917) | 1.92149704 |
| 107 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90677045 |
| 108 | Sepsis (HP:0100806) | 1.90336245 |
| 109 | Diminished motivation (HP:0000745) | 1.90241190 |
| 110 | Hypokalemic alkalosis (HP:0001949) | 1.90107226 |
| 111 | Tetany (HP:0001281) | 1.89624283 |
| 112 | Leukocytosis (HP:0001974) | 1.89571626 |
| 113 | Premature loss of primary teeth (HP:0006323) | 1.89067000 |
| 114 | Polyneuropathy (HP:0001271) | 1.88779576 |
| 115 | Nuclear cataract (HP:0100018) | 1.88205365 |
| 116 | Progressive visual loss (HP:0000529) | 1.88046814 |
| 117 | J-shaped sella turcica (HP:0002680) | 1.87147295 |
| 118 | Abnormality of the renal medulla (HP:0100957) | 1.86119991 |
| 119 | Apathy (HP:0000741) | 1.85817082 |
| 120 | Increased IgM level (HP:0003496) | 1.85016018 |
| 121 | Hypercholesterolemia (HP:0003124) | 1.83914813 |
| 122 | Arterial thrombosis (HP:0004420) | 1.83524245 |
| 123 | Abnormality of renal resorption (HP:0011038) | 1.83035127 |
| 124 | Keratoconjunctivitis (HP:0001096) | 1.82306379 |
| 125 | Increased CSF protein (HP:0002922) | 1.81148578 |
| 126 | Adactyly (HP:0009776) | 1.81045363 |
| 127 | Decreased circulating renin level (HP:0003351) | 1.80630420 |
| 128 | Metabolic alkalosis (HP:0200114) | 1.80068267 |
| 129 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.79962355 |
| 130 | Increased circulating renin level (HP:0000848) | 1.79334671 |
| 131 | Albinism (HP:0001022) | 1.79012966 |
| 132 | Epidermoid cyst (HP:0200040) | 1.77954975 |
| 133 | Abnormality of the periventricular white matter (HP:0002518) | 1.77666005 |
| 134 | Tubular atrophy (HP:0000092) | 1.77643058 |
| 135 | Spondylolisthesis (HP:0003302) | 1.77469958 |
| 136 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77003839 |
| 137 | Menorrhagia (HP:0000132) | 1.76184389 |
| 138 | Attenuation of retinal blood vessels (HP:0007843) | 1.75467326 |
| 139 | Abnormality of the lumbar spine (HP:0100712) | 1.74931225 |
| 140 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.74044827 |
| 141 | Esophageal varix (HP:0002040) | 1.73627093 |
| 142 | Vertebral compression fractures (HP:0002953) | 1.73256797 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 1.72143438 |
| 144 | Abnormality of T cell number (HP:0011839) | 1.71823084 |
| 145 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.70770153 |
| 146 | Progressive neurologic deterioration (HP:0002344) | 1.70617734 |
| 147 | Generalized aminoaciduria (HP:0002909) | 1.70180219 |
| 148 | Gastrointestinal stroma tumor (HP:0100723) | 1.69870945 |
| 149 | Asymmetric septal hypertrophy (HP:0001670) | 1.69556186 |
| 150 | Parakeratosis (HP:0001036) | 1.68703363 |
| 151 | Hematochezia (HP:0002573) | 1.68378900 |
| 152 | Abnormality of the pericardium (HP:0001697) | 1.68013811 |
| 153 | Hypophosphatemic rickets (HP:0004912) | 1.67772652 |
| 154 | Clumsiness (HP:0002312) | 1.67215462 |
| 155 | Increased serum ferritin (HP:0003281) | 1.66933402 |
| 156 | Abnormality of the prostate (HP:0008775) | 1.66152305 |
| 157 | Inability to walk (HP:0002540) | 1.64821641 |
| 158 | Tubulointerstitial abnormality (HP:0001969) | 1.62538517 |
| 159 | Polyphagia (HP:0002591) | 1.62353257 |
| 160 | T lymphocytopenia (HP:0005403) | 1.61985649 |
| 161 | Abnormality of renin-angiotensin system (HP:0000847) | 1.60539436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.51416150 |
| 2 | RIPK4 | 4.75955247 |
| 3 | BLK | 4.02363379 |
| 4 | ACVR1B | 3.74965449 |
| 5 | FRK | 3.73510932 |
| 6 | MAP3K14 | 3.31072094 |
| 7 | TBK1 | 2.94951586 |
| 8 | IRAK3 | 2.87338317 |
| 9 | IRAK4 | 2.67895301 |
| 10 | MAP4K1 | 2.67081267 |
| 11 | WNK3 | 2.60352318 |
| 12 | NTRK2 | 2.39500683 |
| 13 | ERN1 | 2.29471165 |
| 14 | ABL2 | 2.23403839 |
| 15 | TYK2 | 2.10831077 |
| 16 | WNK4 | 2.09894615 |
| 17 | NEK9 | 2.06520359 |
| 18 | MST1R | 2.05661569 |
| 19 | NME2 | 2.00154357 |
| 20 | MAP4K2 | 1.98653963 |
| 21 | IKBKB | 1.89440109 |
| 22 | KIT | 1.89033850 |
| 23 | OXSR1 | 1.85730393 |
| 24 | TXK | 1.75796574 |
| 25 | PIM2 | 1.70722083 |
| 26 | GRK1 | 1.60713712 |
| 27 | PINK1 | 1.60533855 |
| 28 | JAK1 | 1.58687397 |
| 29 | TGFBR2 | 1.56771787 |
| 30 | IKBKE | 1.48413568 |
| 31 | JAK3 | 1.42361209 |
| 32 | SYK | 1.37687714 |
| 33 | MST4 | 1.33637211 |
| 34 | BMX | 1.33480327 |
| 35 | MARK3 | 1.32152591 |
| 36 | DDR2 | 1.28946110 |
| 37 | STK39 | 1.28188545 |
| 38 | HCK | 1.27462975 |
| 39 | TLK1 | 1.27165302 |
| 40 | NUAK1 | 1.26126458 |
| 41 | TRPM7 | 1.25622108 |
| 42 | CSK | 1.25226086 |
| 43 | ZAP70 | 1.23695171 |
| 44 | ZAK | 1.21503515 |
| 45 | LYN | 1.19409328 |
| 46 | ERBB3 | 1.15732957 |
| 47 | MAP2K6 | 1.15484906 |
| 48 | TAOK3 | 1.12592855 |
| 49 | MAP3K10 | 1.11180963 |
| 50 | TNIK | 1.09858556 |
| 51 | FGR | 1.03429771 |
| 52 | GRK7 | 1.01818035 |
| 53 | CHUK | 1.00601666 |
| 54 | MAP3K13 | 1.00475031 |
| 55 | INSRR | 1.00255967 |
| 56 | JAK2 | 0.99746836 |
| 57 | STK4 | 0.95454633 |
| 58 | BTK | 0.95042096 |
| 59 | ARAF | 0.92198134 |
| 60 | CSF1R | 0.89515133 |
| 61 | LCK | 0.89073014 |
| 62 | BMPR2 | 0.88808475 |
| 63 | RPS6KA4 | 0.85814067 |
| 64 | EPHB1 | 0.85447599 |
| 65 | MAP3K12 | 0.85012023 |
| 66 | PIM1 | 0.84503718 |
| 67 | CDC42BPA | 0.84229749 |
| 68 | RIPK1 | 0.83596369 |
| 69 | STK10 | 0.83559660 |
| 70 | TEC | 0.83176973 |
| 71 | PDK2 | 0.81607202 |
| 72 | PRKCD | 0.81416955 |
| 73 | CLK1 | 0.81083080 |
| 74 | MATK | 0.79931377 |
| 75 | ABL1 | 0.78343140 |
| 76 | MAP3K11 | 0.77871659 |
| 77 | MAPK13 | 0.72536833 |
| 78 | YES1 | 0.72279370 |
| 79 | TGFBR1 | 0.72108746 |
| 80 | LRRK2 | 0.71207649 |
| 81 | CSNK1G2 | 0.71191880 |
| 82 | TRIB3 | 0.70532640 |
| 83 | EGFR | 0.70375512 |
| 84 | PRKCG | 0.69764392 |
| 85 | TRIM28 | 0.67144190 |
| 86 | SCYL2 | 0.64716543 |
| 87 | CAMK1D | 0.64640125 |
| 88 | ADRBK1 | 0.64637278 |
| 89 | MAP2K3 | 0.63490482 |
| 90 | CSNK1G3 | 0.63224078 |
| 91 | LIMK1 | 0.62505420 |
| 92 | PKN1 | 0.59994983 |
| 93 | PRKCH | 0.59795502 |
| 94 | FGFR3 | 0.58947668 |
| 95 | IRAK1 | 0.58848356 |
| 96 | CASK | 0.58146568 |
| 97 | CSNK1G1 | 0.57896705 |
| 98 | IRAK2 | 0.53826411 |
| 99 | PRKCQ | 0.53603650 |
| 100 | MAP3K4 | 0.53345560 |
| 101 | TTN | 0.53181633 |
| 102 | ERBB4 | 0.52911263 |
| 103 | FES | 0.51935694 |
| 104 | MOS | 0.51651227 |
| 105 | PDPK1 | 0.50927738 |
| 106 | ITK | 0.50303336 |
| 107 | BCKDK | 0.50085558 |
| 108 | BMPR1B | 0.48728867 |
| 109 | PTK6 | 0.48264864 |
| 110 | PRKCE | 0.48214132 |
| 111 | EPHA3 | 0.47398712 |
| 112 | KSR2 | 0.47301970 |
| 113 | DAPK2 | 0.45433389 |
| 114 | PDK1 | 0.44741902 |
| 115 | MAP3K1 | 0.44074533 |
| 116 | MAP3K3 | 0.42792271 |
| 117 | MAPK15 | 0.42525632 |
| 118 | CAMK1G | 0.42058858 |
| 119 | CSNK1A1L | 0.41859611 |
| 120 | STK3 | 0.41289275 |
| 121 | CAMKK2 | 0.40786102 |
| 122 | MET | 0.40603906 |
| 123 | CSNK1A1 | 0.40434686 |
| 124 | SIK3 | 0.39977207 |
| 125 | FYN | 0.39246434 |
| 126 | DAPK3 | 0.39001215 |
| 127 | ADRBK2 | 0.38169344 |
| 128 | PDGFRB | 0.37519560 |
| 129 | STK16 | 0.36559945 |
| 130 | PRKCA | 0.36362068 |
| 131 | MAP3K5 | 0.36337791 |
| 132 | PLK2 | 0.36227767 |
| 133 | CAMKK1 | 0.35983425 |
| 134 | MUSK | 0.35681705 |
| 135 | CDK6 | 0.35235175 |
| 136 | EIF2AK2 | 0.32970112 |
| 137 | RPS6KA6 | 0.32685239 |
| 138 | MAP3K2 | 0.32576067 |
| 139 | PRKACA | 0.31311761 |
| 140 | PRKAA2 | 0.31094841 |
| 141 | TAOK2 | 0.30878260 |
| 142 | IGF1R | 0.29920519 |
| 143 | EIF2AK3 | 0.29756348 |
| 144 | PAK4 | 0.28453060 |
| 145 | CAMK2A | 0.27915586 |
| 146 | TAOK1 | 0.27545141 |
| 147 | CAMK1 | 0.26830984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.39323476 |
| 2 | * Lysosome_Homo sapiens_hsa04142 | 3.37886222 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.08118214 |
| 4 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.02367193 |
| 5 | * Phagosome_Homo sapiens_hsa04145 | 2.80583073 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.80232018 |
| 7 | * Tuberculosis_Homo sapiens_hsa05152 | 2.69827707 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61435716 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.59629642 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.53639983 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.41353856 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.31901849 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.23203887 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18313416 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.93031602 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90838729 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90744018 |
| 18 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.88850719 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.88681699 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.85385795 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.73456111 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.72905922 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.66690868 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.62954876 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61770650 |
| 26 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.56352092 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55804116 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.53590058 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50902472 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48708049 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.46429376 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44298683 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44231201 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40984335 |
| 35 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.40686902 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.36820984 |
| 37 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34864109 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27940327 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27779056 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27478352 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.26752754 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26016796 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25224936 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24128103 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23108337 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.22980353 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22334264 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 1.21184055 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.20167312 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18805123 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.18659018 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13126751 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11910960 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08185882 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03032002 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 1.02399233 |
| 57 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01862090 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01760762 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94679304 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93650567 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91968703 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91660768 |
| 63 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86769613 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85512358 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84843655 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82898917 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82781833 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.82002786 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.80789284 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80020048 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78933442 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78721189 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77326112 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77158474 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 0.75613270 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73859271 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72559850 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70937559 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69839426 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68176727 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.67087777 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64874073 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63669630 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.62549512 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.61401986 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60476418 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58483116 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58191281 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.57166077 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56865887 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.56749526 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51585082 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.51570731 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50967197 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50293665 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.48799749 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47833454 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.46636270 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46317841 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44140574 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43534410 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41684678 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40361885 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40192946 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39802316 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.38058315 |
| 107 | Protein export_Homo sapiens_hsa03060 | 0.37133287 |
| 108 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.35746218 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35729906 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.35270465 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33610313 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32459120 |
| 113 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.32043719 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31691601 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30890077 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30151413 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29887603 |
| 118 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.28146893 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27705487 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.26484245 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26397132 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.26161632 |
| 123 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25916773 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.25495081 |
| 125 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24992177 |
| 126 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.24602236 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24272524 |
| 128 | GABAergic synapse_Homo sapiens_hsa04727 | 0.22688995 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18896582 |
| 130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18522013 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18502011 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.18350267 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17459017 |
| 134 | Peroxisome_Homo sapiens_hsa04146 | 0.15306137 |
| 135 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.14838854 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14732998 |
| 137 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.12208802 |

